Sk Life Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SK LIFE, and when can generic versions of SK LIFE drugs launch?
SK LIFE has one approved drug.
There are two US patents protecting SK LIFE drugs.
There are twenty-three patent family members on SK LIFE drugs in twenty countries and eleven supplementary protection certificates in ten countries.
Drugs and US Patents for Sk Life
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-005 | Mar 10, 2020 | RX | Yes | No | 11,654,133 | ⤷ Sign Up | ⤷ Sign Up | ||||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-004 | Mar 10, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-005 | Mar 10, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-006 | Mar 10, 2020 | RX | Yes | No | 11,654,133 | ⤷ Sign Up | ⤷ Sign Up | ||||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-001 | Mar 10, 2020 | RX | Yes | Yes | 11,654,133 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Sk Life Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Taiwan | I398249 | ⤷ Sign Up |
South Korea | 20080005437 | ⤷ Sign Up |
China | 101228138 | ⤷ Sign Up |
European Patent Office | 1879873 | ⤷ Sign Up |
European Patent Office | 3768257 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sk Life Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1879873 | 301106 | Netherlands | ⤷ Sign Up | PRODUCT NAME: CENOBAMAAT OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/21/1530 20210330 |
1879873 | CR 2021 00015 | Denmark | ⤷ Sign Up | PRODUCT NAME: CENOBAMAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1530 20210330 |
1879873 | 132021000000101 | Italy | ⤷ Sign Up | PRODUCT NAME: CENOBAMATO(ONTOZRY); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/21/1530, 20210330 |
1879873 | 2190019-6 | Sweden | ⤷ Sign Up | PRODUCT NAME: CENOBAMATE OR A PHARMACEUTICAL ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/21/1530 20210330 |
1879873 | 19/2021 | Austria | ⤷ Sign Up | PRODUCT NAME: CENOBAMAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1530 (MITTEILUNG) 20210330 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.